Home Healthcare Biotechnology Lipid Nanoparticles Market

Lipid Nanoparticles Market Size, Share & Trends Analysis Report By Nanoparticle Type (Liposomes, Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Others), By Molecule Type (siRNA, mRNA, Others), By Application (Therapeutics, Research), By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CDMOs) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 20, 2026 | Author: Dhanashri B | Format: | Report Code: SR8137DR | Pages: 200
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Lipid Nanoparticles Market, By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
    1. Liposomes
    2. Solid Lipid Nanoparticles
    3. Nanostructured Lipid Carriers
    4. Others
  2. Lipid Nanoparticles Market, By Molecule Type 2022-2034 (USD MILLION/ Units)
    1. siRNA
    2. mRNA
    3. Others
  3. Lipid Nanoparticles Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Therapeutics
    2. Research
  4. Lipid Nanoparticles Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biotechnology Companies
    2. Academic & Research Institutes
    3. CROs & CDMOs
  5. Regional Lipid Nanoparticles Market
    1. North America
      1. North America Lipid Nanoparticles Market By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      2. North America Lipid Nanoparticles Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      3. North America Lipid Nanoparticles Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      4. North America Lipid Nanoparticles Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
      5. U.S.
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      6. Canada
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
    2. Europe
      1. Europe Lipid Nanoparticles Market By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      2. Europe Lipid Nanoparticles Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      3. Europe Lipid Nanoparticles Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      4. Europe Lipid Nanoparticles Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
      5. U.K.
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      6. Germany
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      7. France
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      8. Spain
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      9. Italy
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      10. Russia
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      11. Nordic
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      12. Benelux
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      13. Rest of Europe
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
    3. APAC
      1. APAC Lipid Nanoparticles Market By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      2. APAC Lipid Nanoparticles Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      3. APAC Lipid Nanoparticles Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      4. APAC Lipid Nanoparticles Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
      5. China
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      6. Korea
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      7. Japan
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      8. India
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      9. Australia
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      10. Taiwan
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      11. South East Asia
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      12. Rest of Asia-Pacific
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
    4. Middle East and Africa
      1. Middle East and Africa Lipid Nanoparticles Market By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      2. Middle East and Africa Lipid Nanoparticles Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      3. Middle East and Africa Lipid Nanoparticles Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      4. Middle East and Africa Lipid Nanoparticles Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
      5. UAE
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      6. Turkey
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      7. Saudi Arabia
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      8. South Africa
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      9. Egypt
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      10. Nigeria
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      11. Rest of MEA
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
    5. LATAM
      1. LATAM Lipid Nanoparticles Market By Nanoparticle Type 2022-2034 (USD MILLION/ Units)
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
      2. LATAM Lipid Nanoparticles Market By Molecule Type 2022-2034 (USD MILLION/ Units)
        1. siRNA
        2. mRNA
        3. Others
      3. LATAM Lipid Nanoparticles Market By Application 2022-2034 (USD MILLION/ Units)
        1. Therapeutics
        2. Research
      4. LATAM Lipid Nanoparticles Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Academic & Research Institutes
        3. CROs & CDMOs
      5. Brazil
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      6. Mexico
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      7. Argentina
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      8. Chile
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      9. Colombia
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
      10. Rest of LATAM
        1. Liposomes
        2. Solid Lipid Nanoparticles
        3. Nanostructured Lipid Carriers
        4. Others
        5. siRNA
        6. mRNA
        7. Others
        8. Therapeutics
        9. Research
        10. Pharmaceutical & Biotechnology Companies
        11. Academic & Research Institutes
        12. CROs & CDMOs
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.